Update on influenza diagnostics: Lessons from the novel H1N1 influenza A pandemic

Clinical Microbiology Reviews

Volumn 25, Issue 2, 2012, Pages 344-361

  Kumar, Swati ^a,b   Henrickson, Kelly J ^a,b  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

^b Children's Hospital and Health Systems   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADAMANTANE; AMANTADINE; MOLECULAR MARKER; OSELTAMIVIR; RIMANTADINE; SIALIDASE; ZANAMIVIR;

2009 H1N1 INFLUENZA; ANTIVIRAL RESISTANCE; ANTIVIRAL SUSCEPTIBILITY; AUTOMATION; CLINICAL LABORATORY; COMPLEMENT FIXATION TEST; DIAGNOSTIC TEST; DISEASE SURVEILLANCE; ENZYME IMMUNOASSAY; ENZYME INHIBITION; FALSE POSITIVE RESULT; FOOD AND DRUG ADMINISTRATION; GENE MUTATION; HEALTH CARE POLICY; HEMAGGLUTINATION INHIBITION TEST; HIGH THROUGHPUT SEQUENCING; HUMAN; IC 50; IMMUNOGENICITY; INFECTION CONTROL; INFLUENZA A; INFLUENZA B; INFLUENZA VIRUS; INFLUENZA VIRUS A H1N1; INFLUENZA VIRUS A H3N2; INFLUENZA VIRUS A H5N1; LAW; LOOP MEDIATED ISOTHERMAL AMPLIFICATION; MOLECULAR DIAGNOSIS; NUCLEIC ACID AMPLIFICATION; NUCLEIC ACID ANALYSIS; NUCLEIC ACID SEQUENCE BASED AMPLIFICATION; PANDEMIC INFLUENZA; POLYMERASE CHAIN REACTION; PREDICTIVE VALUE; PYROSEQUENCING; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; SENSITIVITY ANALYSIS; SENSITIVITY AND SPECIFICITY; SEROLOGY; SINGLE NUCLEOTIDE POLYMORPHISM; VIRUS CULTURE; VIRUS DETECTION; VIRUS GENOME; VIRUS ISOLATION; VIRUS LOAD; VIRUS REPLICATION;

CLINICAL LABORATORY TECHNIQUES; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA, HUMAN; ORTHOMYXOVIRIDAE; VIROLOGY;

ORTHOMYXOVIRIDAE;

EID: 84859544682     PISSN: 08938512     EISSN: 10986618     Source Type: Journal    
DOI: 10.1128/CMR.05016-11     Document Type: Review

References (132)

1. Adamson WE, et al. 2011. Population exposure to a novel influenza A virus over three waves of infection. J. Clin. Virol. 52:300-303.
2. Andresen DN, Kesson AM. 2010. High sensitivity of a rapid immunochromatographic test for detection of influenza A virus 2009 H1N1 in nasopharyngeal aspirates from young children. J. Clin. Microbiol. 48: 2658-2659.
3. Beck ET, et al. 2010. Development of a rapid automated influenza A, influenza B, and respiratory syncytial virus A/B multiplex real-time RTPCR assay and its use during the 2009 H1N1 swine-origin influenza virus epidemic in Milwaukee, Wisconsin. J. Mol. Diagn. 12:74-81.
4. Bolotin S, et al. 2009. Development of a novel real-time reversetranscriptase PCR method for the detection of H275Y positive influenza A H1N1 isolates. J. Virol. Methods 158:190-194.
5. Bose ME, et al. 2009. Rapid semiautomated subtyping of influenza virus species during the 2009 swine origin influenza A H1N1 virus epidemic in Milwaukee, Wisconsin. J. Clin. Microbiol. 47:2779-2786.
6. Bright RA, Shay DK, Shu B, Cox NJ, Klimov AI. 2006. Adamantane resistance among influenza A viruses isolated early during the 2005-2006 influenza season in the United States. JAMA 295:891-894.
7. Caliendo AM. 2011. Multiplex PCR and emerging technologies for the detection of respiratory pathogens. Clin. Infect. Dis. 52:S326-S330.
8. Carr MJ, et al. 2009. Development of a real-time RT-PCR for the detection of swine-lineage influenza A (H1N1) virus infections. J. Clin. Virol. 45:196-199.
9. Carr S, et al. 2011. Oseltamivir-resistant influenza A and B viruses preand postantiviral therapy in children and young adults with cancer. Pediatr. Infect. Dis. J. 30:284-288.
10. Carrat F, et al. 2008. Time lines of infection and disease in human influenza: a review of volunteer challenge studies. Am. J. Epidemiol. 167:775-785.
11. Centers for Disease Control and Prevention. 2009. Serum crossreactive antibody response to a novel influenza A (H1N1) virus after vaccination with seasonal influenza vaccine. MMWR Morb. Mortal. Wkly. Rep. 58:521-524.
12. Centers for Disease Control and Prevention. 2009. Evaluation of rapid influenza diagnostic tests for detection of novel influenza A (H1N1) virus-United States. MMWR Morb. Mortal. Wkly. Rep. 58:826-829.
13. Centers for Disease Control and Prevention. 2009. Swine influenza A (H1N1) infection in two children-Southern California, March-April 2009. MMWR Morb. Mortal. Wkly. Rep. 58:400-402.
14. Centers for Disease Control and Prevention. 2010. Rapid diagnostic testing for influenza information for health care professionals. http://www.cdc.gov/flu/professionals/diagnosis/rapidclin.htm. Accessed 1 March 2010.
15. Centers for Disease Control and Prevention. 2010. Interim recommendations for clinical use of influenza diagnostic tests during the 2009-10 influenza season. http://www.cdc.gov/h1n1flu/guidance/diagnostic_tests.htm. Accessed 1 March 2010.
16. Centers for Disease Control and Prevention. 2011. 2010-2011 influenza season week 20 ending May 14, 2011. Antiviral resistance. http://www.cdc.gov/flu/weekly/weeklyarchives2010-2011/weekly20.htm.
17. Centers for Disease Control and Prevention. 2009. Performance of rapid influenza diagnostic tests during two school outbreaks of 2009 pandemic influenza A (H1N1) virus infection-Connecticut. MMWR Morb. Mortal. Wkly. Rep. 58:1029-1032.
18. Centers for Disease Control and Prevention. 2008. Infection control measures for preventing and controlling influenza transmission in long-term care facilities; December 2008. http://www.cdc.gov/flu/professionals/infectioncontrol/longtermcare.htm. Accessed 25 January 2010.
19. Centers for Disease Control and Prevention. 2006. High levels of adamantane resistance among influenza A (H3N2) viruses and interim guidelines for use of antiviral agents-United States, 2005-06 influenza season. MMWR Recomm. Rep. 55:44-46.
20. Chen L, et al. 2011. Cluster of oseltamivir-resistant 2009 pandemic influenza A (H1N1) virus infections on a hospital ward among immunocompromised patients-North Carolina, 2009. J. Infect. Dis. 203: 838-846.
21. Chen N, et al. 2011. Ultrasensitive detection of drug-resistant pandemic 2009 (H1N1) influenza A virus by rare-variant-sensitive high-resolution melting-curve analysis. J. Clin. Microbiol. 49:2602-2609.
22. Chidlow GR, et al. 2010. The detection of oseltamivir-resistant pandemic influenza A/H1N1 2009 viruses using a real-time RT-PCR assay. J. Virol. Methods 169:47-51.
23. Choi YJ, et al. 2010. Evaluation of new rapid antigen test for detection of pandemic influenza A/H1N1 2009 virus. J. Clin. Microbiol. 48:2260-2262.
24. Crawford JM, et al. 2010. Laboratory surge response to pandemic (H1N1) 2009 outbreak, New York City metropolitan area, U. S. A. Emerg. Infect. Dis. 16:8-13.
25. Cruz AT, Demmler-Harrison GJ, Caviness AC, Buffone GJ, Revell PA. 2010. Performance of a rapid influenza test in children during the H1N1 2009 influenza A outbreak. Pediatrics 125:e645-e650.
26. Cunha BA, Thekkel V, Cohan C. 2010. H1N1 influenza: contact investigation burden because of failure to institute influenza precautions in patients with negative rapid influenza diagnostic test results. Infect. Control Hosp. Epidemiol. 31:102-104.
27. Cunha BA, Syed U, Strollo S, Mickail N, Laguerre M. 2010. Rapid clinical diagnosis in fatal swine influenza (H1N1) pneumonia in an adult with negative rapid influenza diagnostic tests (RIDTs): diagnostic swine influenza triad. Heart Lung 39:461.
28. Dale SE, Mayer C, Mayer MC, Menegus MA. 2008. Analytical and clinical sensitivity of the3Mrapid detection influenza A+B assay. J. Clin. Microbiol. 46:3804-3807.
29. Daley P, Castriciano S, Chernesky M, Smieja M. 2006. Comparison of flocked and rayon swabs for collection of respiratory epithelial cells from uninfected volunteers and symptomatic patients. J. Clin. Microbiol. 44: 2265-2267.
30. Deng YM, et al. 2011. A comparison of pyrosequencing and neuraminidase inhibition assays for the detection of oseltamivir-resistant pandemic influenza A(H1N1) 2009 viruses. Antiviral Res. 90:87-91.
31. Deyde VM, et al. 2010. Detection of molecular markers of drug resistance in 2009 pandemic influenza A (H1N1) viruses by pyrosequencing. Antimicrob. Agents Chemother. 54:1102-1110.
32. Deyde VM, et al. 2009. Pyrosequencing as a tool to detect molecular markers of resistance to neuraminidase inhibitors in seasonal influenza A viruses. Antiviral Res. 81:16-24.
33. Deyde VM, et al. 2009. Detection of molecular markers of antiviral resistance in influenza A (H5N1) viruses using a pyrosequencing method. Antimicrob. Agents Chemother. 53:1039-1047.
34. Dhiman N, et al. 2010. Mutability in the matrix gene of novel influenza A H1N1 virus detected using a FRET probe-based real-time reverse transcriptase PCR assay. J. Clin. Microbiol. 48:677-679.
35. Dhiman N, et al. 2010. Evidence for amino acid changes in a 57-basepair region of the highly conserved matrix gene of pandemic (H1N1) 2009 influenza A virus. J. Clin. Microbiol. 48:3817-3819.
36. Drexler JF, et al. 2009. Poor clinical sensitivity of rapid antigen test for influenza A pandemic (H1N1) 2009 virus. Emerg. Infect. Dis. 15:1662-1664.
37. Faix DJ, Sherma SS, Waterman SH. 2009. Rapid-test sensitivity for novel swine-origin influenza A (H1N1) virus in humans. N. Engl. J. Med. 361:728-729.
38. Falchi A, et al. 2008. Dual infections by influenza A/H3N2 and B viruses and by influenza A/H3N2 and A/H1N1 viruses during winter 2007, Corsica Island, France. J. Clin. Virol. 41:148-151.
39. Fan J, Henrickson KJ. 1998. Rapid simultaneous diagnosis of RSV A, B, influenza A, B, human parainfluenza virus type 1, 2, and 3 infection by multiplex quantitative RT-PCR enzyme hybridization (HexaplexTM) assay. Clin. Infect. Dis. 26:1397-1402.
40. Fiore AE, et al. 2011. Antiviral agents for the treatment and chemoprophylaxis of influenza-recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm. Rep. 60:1-24.
41. Furuse Y, et al. 2009. Reversion of influenza A (H3N2) virus from amantadine resistant to amantadine sensitive by further reassortment in Japan during the 2006-to-2007 influenza season. J. Clin. Microbiol. 47: 841-844.
42. Furuse Y, et al. 2009. Reassortment between amantadine-resistant and -sensitive H1N1 influenza A viruses generated an amantadine-sensitive virus during the 2007-2008 season. J. Infect. Dis. 200:1766-1773.
43. Furuse Y, et al. 2010. Occurrence of mixed populations of influenza A viruses that can be maintained through transmission in a single host and potential for reassortment. J. Clin. Microbiol. 48:369-374.
44. Ghedin E, et al. 2011. Deep sequencing reveals mixed infection with 2009 pandemic influenza A (H1N1) virus strains and the emergence of oseltamivir resistance. J. Infect. Dis. 203:168-174.
45. Ginocchio CC. 2011. Strengths and weaknesses of FDA-approved/cleared diagnostic devices for the molecular detection of respiratory pathogens. Clin. Infect. Dis. 52(Suppl 4):S312-S325.
46. Ginocchio CC. 2007. Detection of respiratory viruses using nonmolecular based methods. J. Clin. Virol. 40(Suppl 1):S11-S14.
47. Ginocchio CC, et al. 2009. Clinical performance of the 3M Rapid Detection Flu A+B test compared to R-Mix culture, DFA and Binax NOW Influenza A&B test. J. Clin. Virol. 45:146-149.
48. Ginocchio CC, St George K. 2009. Likelihood that an unsubtypeable influenza A virus result obtained with the Luminex xTAG respiratory virus panel is indicative of infection with novel A/H1N1 (swine-like) influenza virus. J. Clin. Microbiol. 47:2347-2348.
49. Ginocchio CC, et al. 2009. Evaluation of multiple test methods for the detection of the novel 2009 influenza A (H1N1) during the New York City outbreak. J. Clin. Virol. 45:191-195.
50. Graitcer SB, et al. 2011. Characteristics of patients with oseltamivirresistant pandemic (H1N1) 2009, United States. Emerg. Infect. Dis. 17: 255-257.
51. Grijalva CG, et al. 2007. Accuracy and interpretation of rapid influenza tests in children. Pediatrics 119:e6-e11.
52. Gubareva LV, Matrosovich MN, Brenner MK, Bethell RC, Webster RG. 1998. Evidence for zanamivir resistance in an immunocompromised child infected with influenza B virus. J. Infect. Dis. 178:1257-1262.
53. Gubareva LV. 2004. Molecular mechanisms of influenza virus resistance to neuraminidase inhibitors. Virus Res. 103:199-203.
54. Hancock K, et al. 2009. Cross-reactive antibody responses to the 2009 pandemic H1N1 influenza virus. N. Engl. J. Med. 361:1945-1952.
55. Harrington K, Khanna M, Waters CR, Henrickson KJ. 2004. Adenoplex: rapid detection and identification of human adenovirus species by a multiplex PCR-EHA based assay. J. Clin. Microbiol. 42:4072-4076.
56. Hatano B, et al. 2011. Mobile and accurate detection system for infection by the 2009 pandemic influenza A (H1N1) virus with a pocket-warmer reverse-transcriptase loop-mediated isothermal amplification. J. Med. Virol. 83:568-573.
57. Hayden RT, et al. 2010. A survey-based assessment of United States clinical laboratory response to the 2009 H1N1 influenza outbreak. Arch. Pathol. Lab. Med. 134:1671-1678.
58. He J, et al. 2009. Rapid multiplex reverse transcription-PCR typing of influenza A and B virus, and subtyping of influenza A virus into H1, 2, 3, 5, 7, 9, N1 (human), N1 (animal), N2, and N7, including typing of novel swine origin influenza A (H1N1) virus, during the 2009 outbreak in Milwaukee, Wisconsin. J. Clin. Microbiol. 47:2772-2778.
59. Henrickson KJ, Hoover S, Kehl S. 2004. National disease burden of respiratory viruses detected in children using PCR. Pediatr. Infect. Dis. J. 23:S11-S18.
60. Henrickson KJ. 2004. Advances in the laboratory diagnosis of viral respiratory disease. Pediatr. Infect. Dis. J. 23:S6-S10.
61. Hindiyeh M, et al. 2010. Rapid detection of influenza A pandemic (H1N1) 2009 virus neuraminidase resistance mutation H275Y by realtime reverse transcriptase PCR. J. Clin. Microbiol. 48:1884-1887.
62. Huang Y, et al. 2009. Multiplex assay for simultaneously typing and subtyping influenza viruses by use of an electronic microarray. J. Clin. Microbiol. 47:390-396.
63. Hurt AC, et al. 2009. Performance of influenza rapid point-of-care tests in the detection of swine lineage A (H1N1) influenza viruses. Influenza Other Respi. Viruses 3:171-176.
64. Hurt AC, Holien JK, Parker M, Kelso A, Barr IG. 2009. Zanamivirresistant influenza viruses with a novel neuraminidase mutation. J. Virol. 83:10366-10373.
65. Hurt AC, Ho HT, Barr I. 2006. Resistance to anti-influenza drugs: adamantanes and neuraminidase inhibitors. Expert Rev. Anti Infect. Ther. 4:795-805.
66. Hymas WC, et al. 2010. Development of a multiplex real-time RT-PCR assay for detection of influenza A, influenza B, RSV and typing of the 2009-H1N1 influenza virus. J. Virol. Methods 167:113-118.
67. Ison MG, Gubareva LV, Atmar RL, Treanor J, Hayden FG. 2006. Recovery of drug-resistant influenza virus from immunocompromised patients: a case series. J. Infect. Dis. 193:760-764.
68. Janies DA, et al. 2010. Selection for resistance to oseltamivir in seasonal and pandemic H1N1 influenza and widespread co-circulation of the lineages. Int. J. Health Geogr. 9:13.
69. Jayawardena S, et al. 2007. Loop-mediated isothermal amplification for influenza A (H5N1) virus. Emerg. Infect. Dis. 13:899-901.
70. Jernigan DB, et al. 2011. Detecting 2009 pandemic influenza A (H1N1) virus infection: availability of diagnostic testing led to rapid pandemic response. Clin. Infect. Dis. 52:S36-S43.
71. Katz JM, Hancock K, Xu X. 2011. Serologic assays for influenza surveillance, diagnosis and vaccine evaluation. Expert Rev. Anti Infect. Ther. 9:669-683.
72. Kehl S, Henrickson KJ. 2001. Comparison of three diagnostic methods, Hexaplex, tissue culture, and rapid EIA, for the detection of respiratory viruses in children. J. Clin. Microbiol. 39:1696-1701.
73. Khanna M, et al. 2005. The Pneumoplex: a multiplex PCR-EHA based assay simultaneously detects Mycoplasma pneumoniae, Chlamydia pneumoniae, Legionella pneumophila and micdadei, and Bordetella pertussis infections in a single test. J. Clin. Microbiol. 43:565-571.
74. Kim YK, Uh Y, Chun JK, Kim C, Kim HY. 2010. Evaluation of new hemagglutinin-based rapid antigen test for influenza A pandemic (H1N1) 2009. J. Clin. Virol. 49:69-72.
75. Kiso M, et al. 2004. Resistant influenza A viruses in children treated with oseltamivir: descriptive study. Lancet 364:759-765.
76. Klungthong C, et al. 2010. The impact of primer and probe-template mismatches on the sensitivity of pandemic influenza A/H1N1/2009 virus detection by real-time RT-PCR. J. Clin. Virol. 48:91-95.
77. Kubo T, et al. 2010. Development of a reverse transcription-loopmediated isothermal amplification assay for detection of pandemic (H1N1) 2009 virus as a novel molecular method for diagnosis of pandemic influenza in resource-limited settings. J. Clin. Microbiol. 48:728-735.
78. Kumar S, et al. 2009. Introduction of a novel swine-origin influenza A (H1N1) virus into Milwaukee, Wisconsin in 2009. Viruses 1:72-83.
79. Kumar S, et al. 2010. Epidemiologic observations from passive and targeted surveillance during the first wave of the 2009 H1N1 influenza pandemic in Milwaukee, WI. Viruses 2:782-795.
80. Kumar S, et al. 2008. Detection of 11 common viral and bacterial pathogens causing community-acquired pneumonia or sepsis in asymptomatic patients using multiplex RT-PCR assay with manual (enzyme hybridization) or automated (electronic microarray) detection. J. Clin. Microbiol. 46:3063-3072.
81. Kwon D, et al. 2011. Development and evaluation of a rapid influenza diagnostic test for the pandemic (H1N1) 2009 influenza virus. J. Clin. Microbiol. 49:437-438.
82. Lackenby A, Democratis J, Siqueira MM, Zambon MC. 2008. Rapid quantitation of neuraminidase inhibitor drug resistance in influenza virus quasispecies. Antivir. Ther. 13:809-820.
83. Landry ML. 2011. Diagnostic tests for influenza infection. Curr. Opin. Pediatr. 23:91-97.
84. Laplante JM, et al. 2009. Influenza antiviral resistance testing in New York and Wisconsin, 2006 to 2008: methodology and surveillance data. J. Clin. Microbiol. 47:1372-1378.
85. Lee CS, Lee JH, Kim CH. 2011. Time-dependent sensitivity of a rapid antigen test in patients with 2009 H1N1 influenza. J. Clin. Microbiol. 49:1702.
86. Leland DS, Ginocchio CC. 2007. Role of cell culture for virus detection in the age of technology. Clin. Microbiol. Rev. 20:49-78.
87. Likitnukul S, Boonsiri K, Tangsuksant Y. 2009. Evaluation of sensitivity and specificity of rapid influenza diagnostic tests for novel swine-origin influenza A (H1N1) virus. Pediatr. Infect. Dis. J. 28:1038-1039.
88. Ma XJ, et al. 2010. Visual detection of pandemic influenza A H1N1 virus 2009 by reverse-transcription loop-mediated isothermal amplification with hydroxynaphthol blue dye. J. Virol. Methods 167:214-217.
89. Mahony JB. 2008. Detection of respiratory viruses by molecular methods. Clin. Microbiol. Rev. 21:716-747.
90. Mahony JB. 2010. Nucleic acid amplification-based diagnosis of respiratory virus infections. Expert Rev. Anti Infect. Ther. 8:1273-1292.
91. McCloskey CB, et al. 2011. Characterization of 2009 pandemic influenza A (H1N1) virus specimens with a positive hemagglutinin 1 signal in the Luminex xTAG respiratory viral panel assay. J. Clin. Microbiol. 49: 1657-1658.
92. Mehta T, et al. 2010. Detection of oseltamivir resistance during treatment of 2009 H1N1 influenza virus infection in immunocompromised patients: utility of cycle threshold values of qualitative real-time reverse transcriptase PCR. J. Clin. Microbiol. 48:4326-4328.
93. Mohr PG, Geyer H, McKimm-Breschkin JL. 2011. Mixed influenza A and B infections complicate the detection of influenza viruses with altered sensitivities to neuraminidase inhibitors. Antiviral Res. 91:20-22.
94. Nakauchi M, et al. 2011. Evaluation of reverse transcription loopmediated isothermal amplification assays for rapid diagnosis of pandemic influenza A/H1N1 2009 virus. J. Med. Virol. 83:10-15.
95. Nelson M, et al. 2009. The early diversification of influenza A/H1N1pdm. PLoS Curr. 1:RRN1126.
96. Nijhuis M, van Maarseveen NM, Boucher CA. 2009. Antiviral resistance and impact on viral replication capacity: evolution of viruses under antiviral pressure occurs in three phases. Handbook Exp. Pharmacol. 189:299-320.
97. Notomi T, et al. 2000. Loop-mediated isothermal amplification of DNA. Nucleic Acids Res. 28:E63.
98. Nowak JA, Kaul KL. 2009. The role of community molecular diagnostics laboratories in the H1N1 pandemic. J. Mol. Diagn. 11:369-370.
99. Okomo-Adhiambo M, et al. 2010. Detection of E119V and E119I mutations in influenza A (H3N2) viruses isolated from an immunocompromised patient: challenges in diagnosis of oseltamivir resistance. Antimicrob. Agents Chemother. 54:1834-1841.
100. Okomo-Adhiambo M, et al. 2010. Host cell selection of influenza neuraminidase variants: implications for drug resistance monitoring in A(H1N1) viruses. Antiviral Res. 85:381-388.
101. Operario DJ, Moser MJ, St George K. 2010. Highly sensitive and quantitative detection of the H274Y oseltamivir resistance mutation in seasonal A/H1N1 influenza virus. J. Clin. Microbiol. 48:3517-3524.
102. Pabbaraju K, et al. 2009. Design and validation of real-time reverse transcription-PCR assays for detection of pandemic (H1N1) 2009 virus. J. Clin. Microbiol. 47:3454-3460.
103. Pan C, et al. 2010. Genomic signature and mutation trend analysis of pandemic (H1N1) 2009 influenza A virus. PLoS One 5:e9549.
104. Parida M, Sannarangaiah S, Dash PK, Rao PV, Morita K. 2008. Loop mediated isothermal amplification (LAMP): a new generation of inno-vative gene amplification technique; perspectives in clinical diagnosis of infectious diseases. Rev. Med. Virol. 18:407-421.
105. Patel P, et al. 2011. RapidSTRIPE H1N1 test for detection of the pandemic swine origin influenza A (H1N1) virus. J. Clin. Microbiol. 49: 1591-1593.
106. Petric M, Comanor L, Petti CA. 2006. Role of the laboratory in diagnosis of influenza during seasonal epidemics and potential pandemics. J. Infect. Dis. 194:S98-S110.
107. Poon LL, et al. 2005. Detection of human influenza A viruses by loopmediated isothermal amplification. J. Clin. Microbiol. 43:427-430.
108. Potter CW, Oxford JS. 1979. Determinants of immunity to influenza infection in man. Br. Med. Bull. 35:69-75.
109. Rameix-Welti MA, et al. 2006. Natural variation can significantly alter the sensitivity of influenza A (H5N1) viruses to oseltamivir. Antimicrob. Agents Chemother. 50:3809-3815.
110. Renaud C, Kuypers J, Corey L. 2010. Diagnostic accuracy of an allelespecific reverse transcriptase-PCR assay targeting the H275Y oseltamivir resistant mutation in 2009 pandemic influenza A/H1N1 virus. J. Clin. Virol. 49:21-25.
111. Sambol AR, et al. 2010. Use of rapid influenza diagnostic tests under field conditions as a screening tool during an outbreak of the 2009 novel influenza virus: practical considerations. J. Clin. Virol. 47:229-233.
112. Sheu TG, et al. 2011. Dual resistance to adamantanes and oseltamivir among seasonal influenza A (H1N1) viruses: 2008-2010. J. Infect. Dis. 203:13-17.
113. Sheu TG, et al. 2008. Surveillance for neuraminidase inhibitor resistance among human influenza A and B viruses circulating worldwide from 2004 to 2008. Antimicrob. Agents Chemother. 52:3284-3292.
114. Sheu TG, Deyde VM, Garten RJ, Klimov AI, Gubareva LV. 2010. Detection of antiviral resistance and genetic lineage markers in influenza B virus neuraminidase using pyrosequencing. Antiviral Res. 85:354-360.
115. Stevenson HL, Loeffelholz MJ. 2010. Poor positive accuracy of Quick-Vue rapid antigen tests during the influenza A (H1N1) 2009 pandemic. J. Clin. Microbiol. 48:3729-3731.
116. Sugaya N, et al. 2007. Lower clinical effectiveness of oseltamivir against influenza B contrasted with influenza A infection in children. Clin. Infect. Dis. 44:197-202.
117. Suntarattiwong P, et al. 2010. Clinical performance of a rapid influenza test and comparison of nasal versus throat swabs to detect 2009 pandemic influenza A (H1N1) infection in Thai children. Pediatr. Infect. Dis. J. 29:366-367.
118. Tamura D, et al. 2011. Frequency of drug-resistant viruses and virus shedding in pediatric influenza patients treated with neuraminidase inhibitors. Clin. Infect. Dis. 52:432-437.
119. Thorlund K, Awad T, Boivin G, Thabane L. 2011. Systematic review of influenza resistance to the neuraminidase inhibitors. BMC Infect. Dis. 11:134.
120. Uyeki TM, et al. 2009. Low sensitivity of rapid diagnostic test for influenza. Clin. Infect. Dis. 48:e89-e92.
121. van der Vries E, et al. 2010. Evaluation of a rapid molecular algorithm for detection of pandemic influenza A (H1N1) 2009 virus and screening for a key oseltamivir resistance (H275Y) substitution in neuraminidase. J. Clin. Virol. 47:34-37.
122. Vasoo S, Stevens J, Singh K. 2009. Rapid antigen tests for diagnosis of pandemic (swine) influenza A/H1N1. Clin. Infect. Dis. 49:1090-1093.
123. Veguilla V, et al. 2011. Sensitivity and specificity of serologic assays for detection of human infection with 2009 pandemic H1N1 virus in U.S. populations. J. Clin. Microbiol. 49:2210-2215.
124. Ward P, Small I, Smith J, Suter P, Dutkowski R. 2005. Oseltamivir (Tamiflu) and its potential for use in the event of an influenza pandemic. J. Antimicrob. Chemother. 55(Suppl 1):i5-i21.
125. Welch DF, Ginocchio CC. 2010. Role of rapid immunochromatographic antigen testing in diagnosis of influenza A virus 2009 H1N1 infection. J. Clin. Microbiol. 48:22-25.
126. Whitley RJ, et al. 2001. Oral oseltamivir treatment of influenza in children. Pediatr. Infect. Dis. J. 20:127-133.
127. World Health Organization. 2009. CDC protocol of real-time RT-PCR for influenza A (H1N1). http://www.who.int/entity/csr/resources/publications/swineflu/CDCRealtimeRTPCR_SwineH1Assay-2009_20090430.pdf.
128. Wu W, Tang YW. 2009. Emerging molecular assays for detection and characterization of respiratory viruses. Clin. Lab. Med. 29:673-693.
129. Wu LT, et al. 2010. Nucleic acid dipstick test for molecular diagnosis of pandemic H1N1. J. Clin. Microbiol. 48:3608-3613.
130. Zhang WD, Evans DH. 1991. Detection and identification of human influenza viruses by the polymerase chain reaction. J. Virol. Methods 33:165-189.
131. Zhang S, Zhang W, Tang YW. 2011. Molecular diagnosis of viral respiratory infections. Curr. Infect. Dis. Rep. 13:149-158.
132. Zheng X, Todd KM, Yen-Lieberman B, Kaul KK, Mangold Shulman ST. 2010. Unique finding of a 2009 H1N1 influenza virus-positive clinical sample suggests matrix gene sequence variation. J. Clin. Microbiol. 48:665-666.